Page 139 - GPD-4-2
P. 139

Gene & Protein in Disease                                         Binding of 11q to DENV and WNV proteases



               doi: 10.3389/fmed.2022.921060                      doi: 10.3389/fcimb.2023.1061937
            22.  Yadav R, Jena NR. Paritaprevir as a pan-antiviral against   33.  Liu X, Liang J, Yu Y, et al. Discovery of aryl benzoyl hydrazide
               different flaviviruses. Front Mol Biosci. 2025;12:1524951.  derivatives  as  novel potent  broad-spectrum  inhibitors  of
                                                                  influenza A virus RNA-dependent RNA polymerase (RdRp).
               doi: 10.3389/fmolb.2025.1524951
                                                                  J Med Chem. 2022;65(5):3814-3832.
            23.  Pant S, Jena NR. Repurposing of antiparasitic drugs against      doi: 10.1021/acs.jmedchem.1c01257
               the NS2B-NS3 protease of the Zika virus. J Biomol Struct
               Dyn. 2023;42:10101-10113.                       34.  Yao Y, Huo T, Lin YL, et al. Discovery, X-ray crystallography
                                                                  and antiviral activity of allosteric inhibitors of flavivirus
               doi: 10.1080/07391102.2023.2255648                 NS2B-NS3 protease. J Am Chem Soc. 2019;141(17):6832-6836.
            24.  Li Y, Zhang Z, Phoo WW, et al. Structural dynamics of Zika      doi: 10.1021/jacs.9b02505
               virus NS2B-NS3 protease binding to dipeptide inhibitors.
               Structure. 2017;25(8):1242-1250.e3.             35.  Chang HH, Huber RG, Bond PJ, et al. Systematic analysis
                                                                  of protein identity between Zika virus and other arthropod-
               doi: 10.1016/j.str.2017.06.006                     borne viruses. Bull World Health Organ. 2016;95(7):517-525.
            25.  Li Y, Zhang Z, Phoo WW, et al. Structural insights into the      doi: 10.2471/BLT.16.182105
               inhibition of Zika virus NS2B-NS3 protease by a small-
               molecule inhibitor. Structure. 2018;26(4):555-564.e3.  36.  Huber RG, Lim XN, Ng WC, et al. Structure mapping of
                                                                  dengue and Zika viruses reveals functional long-range
               doi: 10.1016/j.str.2018.02.005                     interactions. Nat Commun. 2019;10(1):1408.
            26.  Pant S, Bhattacharya G, Jena NR. Structures and dynamics      doi: 10.1038/s41467-019-09391-8
               of peptide and peptidomimetic inhibitors bound to the
               NS2B-NS3 protease of the ZIKA virus. J Biomol Struct Dyn.   37.  Klamt A, Mennucci B, Tomasi J, et al. On the performance
               2023;41(7):3076-3088.                              of continuum solvation methods. A comment on “Universal
                                                                  approaches to solvation modeling.”  Acc Chem Res.
               doi: 10.1080/07391102.2022.2045223                 2009;42(4):489-492.
            27.  Phoo WW, Zhang Z, Wirawan M, et al. Structures of Zika      doi: 10.1021/ar800187p
               virus NS2B-NS3 protease in complex with peptidomimetic
               inhibitors. Antivir Res. 2018;160:17-24.        38.  Dennington R, Keith T, Millam J. GaussView V. 5. Shawnee
                                                                  Mission: Semichem Inc.; 2009.
               doi: 10.1016/j.antiviral.2018.10.006
                                                               39.  Yadav RP, Jena NR. Aryl benzoyl hydrazide derivatives as
            28.  Yang CC, Hsieh YC, Lee SJ, et al. Novel dengue virus-specific   the potent inhibitors of the NS2B-NS3 protease and RNA-
               NS2B/NS3 protease inhibitor, BP2109, discovered by a high-  dependent RNA polymerase of the zika virus, 2025, (under
               throughput screening assay. Antimicrob Agents Chemother.   review).
               2011;55(1):229-238.
                                                               40.  Trott O, Olson AJ. AutoDock Vina: Improving the speed
               doi: 10.1128/AAC.00855-10                          and accuracy of docking with a new scoring function,
                                                                  efficient optimization, and multithreading. J Comput Chem.
            29.  Baltina LA, Tasi YT, Huang SH,  et al. Glycyrrhizic acid   2010;31(2):455-461.
               derivatives as dengue virus inhibitors.  Bioorg Med Chem
               Lett. 2019;29(20):126645.                          doi: 10.1002/jcc.21334
               doi: 10.1016/j.bmcl.2019.126645                 41.  Blum C, Roli A, Sampels M.  Hybrid Metaheuristics: An
                                                                  Emerging Approach to Optimization. Vol  114. Germany:
            30.  Lai H, Prasad GS, Padmanabhan R. Characterization   Springer; 2008.
               of    8-hydroxyquinoline  derivatives  containing
               aminobenzothiazole as inhibitors of dengue virus type  2      doi: 10.1007/978-3-540-78295-7
               protease in vitro. Antivir Res. 2013;97(1):74-80.  42.  Baxter J. Local optima avoidance in depot location. J Oper
               doi: 10.1016/j.antiviral.2012.10.009               Res Soc. 1981;32(9):815-819.
            31.  Dang M, Lim  L, Roy A, Song  J. Myricetin  Allosterically   43.  Mark P, Nilsson L. Structure and dynamics of the TIP3P,
               Inhibits Dengue NS2B-NS3 Protease as Studied by NMR   SPC, and SPC/E water models at 298 K.  J  Phys Chem A.
               and MD Simulations. bioRxiv. 2021.                 2001;105(43):9954-9960.
               doi: 10.1101/2021.12.13.472523                     doi: 10.1021/jp003020w
            32.  Norshidah H, Leow CH, Ezleen KE,  et al. Assessing the   44.  Onufriev AV, Izadi S. Water models for biomolecular
               potential of NS2B/NS3 protease inhibitors biomarker   simulations.  Wiley Interdiscip Rev Comput Mol Sci.
               in curbing dengue virus infections:  In silico vs.  In vitro   2018;8(2):e1347.
               approach. Front Cell Infect Microbiol. 2023;13:1061937.     doi: 10.1002/wcms.1347


            Volume 4 Issue 2 (2025)                         10                              doi: 10.36922/gpd.8293
   134   135   136   137   138   139   140   141   142   143   144